Figure 6
Comparison of A304V mutant versus wild-type MCP in inhibiting the alternative pathway. FACS analysis of C3d deposition using 1, 4, or 8.3 mg/mL of sensitizing Ab with 10% or 30% C7d serum for 60 minutes in Mg2+-EGTA. Representative experiment of 3. See Table 4 for MFIs.
